Qun Niu
Chengdu, 610075, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: Multidimensional analysis reveals the potential of ACSL3 as a cancer biomarker: from pan-cancer exploration to functional validation in hepatocellular carcinoma.
Journal: Clinical and experimental medicine
Published: November 25, 2025
The role of PD‑1/PD‑L1 axis in liver diseases.
Journal: Clinical and experimental medicine
Published: October 07, 2025
Comprehensive pan-cancer characterization of IRAK2 as a potential prognostic biomarker and therapeutic target with validation in hepatocellular carcinoma.
Journal: BMC cancer
Published: September 05, 2025
Multidimensional analysis reveals the potential of ACSL3 as a cancer biomarker: from pan-cancer exploration to functional validation in hepatocellular carcinoma.
Journal: Clinical and experimental medicine
Published: August 19, 2025
Natural medicines for treating liver fibrosis by modulating post-translational modifications.
Journal: Frontiers in pharmacology
Published: July 07, 2025
Research progress on the role of efferocytosis in liver diseases
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: January 12, 2025
Qizhu Rougan Granules suppress liver fibrosis by inhibiting the expression of the P2Y14 receptor on hepatic stellate cells.
Journal: Frontiers in pharmacology
Published: November 14, 2024
The role of the interleukin family in liver fibrosis.
Journal: Frontiers in immunology
Published: September 16, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026